Literature DB >> 17189618

Vascular endothelial growth factor promotes brain tissue regeneration with a novel biomaterial polydimethylsiloxane-tetraethoxysilane.

HanZhe Zhang1, Takeshi Hayashi, Kanji Tsuru, Kentaro Deguchi, Mitsuyuki Nagahara, Satoshi Hayakawa, Makiko Nagai, Tatsushi Kamiya, Akiyoshi Osaka, Koji Abe.   

Abstract

In the brain after infarction or trauma, the tissue eventually becomes pannecrotic and forms a cavity. In such situations, a scaffold is necessary for the implanted or migrated cells to produce new tissue. In this present study, therefore, we attempted to restore brain tissue using a novel biomaterial, polydimethylsiloxane-tetraethoxysilane (PDMS-TEOS) hybrid with or without vascular endothelial growth factor (VEGF), which is crucial for new vessel formation. When PDMS-TEOS scaffold was implanted into the artificial brain defect, it remained at the implanted site and kept the integrity of the brain shape. At 30 days after the implantation, the marginal territory of PDMS-TEOS scaffold became occupied by newly formed tissue. Immunohistochemical analysis revealed that the new tissue was constituted by astrocytes and endothelial cells. Addition of VEGF increased the newly produced tissue volume, and the immunohistochemical analysis showed that the numbers of astrocytes and endothelial cells were increased. Double staining with proliferation maker Ki67 demonstrated that VEGF significantly increased newly formed astrocytes and endothelial cells, indicating that addition of VEGF accelerated tissue restoration and angiogenesis. These findings show that implantation of PDMS-TEOS scaffold with VEGF might be effective for treating old brain infarction or trauma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189618     DOI: 10.1016/j.brainres.2006.09.117

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Regenerative therapies for central nervous system diseases: a biomaterials approach.

Authors:  Roger Y Tam; Tobias Fuehrmann; Nikolaos Mitrousis; Molly S Shoichet
Journal:  Neuropsychopharmacology       Date:  2013-09-04       Impact factor: 7.853

2.  Rapid vascularization of tissue-engineered vascular grafts in vivo by endothelial cells in co-culture with smooth muscle cells.

Authors:  Zhenyu Wang; Yanzhong He; Xindi Yu; Wei Fu; Wei Wang; Huimin Huang
Journal:  J Mater Sci Mater Med       Date:  2012-02-14       Impact factor: 3.896

Review 3.  Prospects for engineering neurons from local neocortical cell populations as cell-mediated therapy for neurological disorders.

Authors:  Stanley Bazarek; Daniel A Peterson
Journal:  J Comp Neurol       Date:  2014-05-13       Impact factor: 3.215

4.  Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles.

Authors:  Ellen Bible; Omar Qutachi; David Y S Chau; Morgan R Alexander; Kevin M Shakesheff; Michel Modo
Journal:  Biomaterials       Date:  2012-07-18       Impact factor: 15.304

Review 5.  Extracellular matrices, artificial neural scaffolds and the promise of neural regeneration.

Authors:  Christian B Ricks; Samuel S Shin; Christopher Becker; Ramesh Grandhi
Journal:  Neural Regen Res       Date:  2014-09-01       Impact factor: 5.135

Review 6.  Regenerative Medicine Therapies for Targeting Neuroinflammation After Stroke.

Authors:  Olivera Rajkovic; Geoffrey Potjewyd; Emmanuel Pinteaux
Journal:  Front Neurol       Date:  2018-09-03       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.